Listed pharmaceutical companies has experiences ‘financial declines while mid-sized pharmaceutical companies made ‘improvements’

Due to enforcement of the ‘Rebate Two Out Policy’, top and small pharmaceutical companies are financially declined, but it is known that mid-sized pharmaceutical companies had a small step forward with their aggressive sales strategies.

Through his recent report titled the ‘Third Quarter Performance Review of Domestic Listed Pharmaceutical Companies’, Kyung-cheol Roh, an analyst of IM Investme...